Amgen Inc. discovers, develops, manufactures and delivers human therapeutics worldwide. It focuses on the areas of inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology and neuroscience. It has agreements with Novartis Pharma; Bayer HealthCar and Eli Lilly.
Revenue TTM 25.4B
Net Income TTM 5.7B
EBITDA TTM 12.43B
Net Margin TTM 22.5%
Dividend yield 3.27%.
Revenue TTM 25.4B
Net Income TTM 5.7B
EBITDA TTM 12.43B
Net Margin TTM 22.5%
Dividend yield 3.27%.
Trading ditutup: stop tercapai:
Oct 12